Healthcare 4.0 has changed dramatically over the last century. It is evolving daily, with physicians and researchers alike developing new tools strategies. This study analyzes impact of Industry on healthcare (IHC) systems. Therefore, using PRISMA 2015, a systematic literature review was undertaken utilizing articles retrieved from Scopus Web Science. A bibliometric qualitative assessment 346 4...

Drawing on the knowledge-based perspective, this research developed and tested a model consisting of five technological innovation characteristics (relative advantage, complexity, compatibility, observability, triability) as antecedents, green mediator, sustainable competitive advantage an outcome, government environmental support moderator. A survey was administered to 305 participants from Mi...

Much of the focus on the future of the pharmaceutical industry in the United States has been on the very real challenges of research productivity, the development of compelling clinical evidence demonstrating product effectiveness, post-marketing safety, and threats to pricing and reimbursement. Industry leaders, however, have paid less attention to the trends in the overall healthcare system t...

This case examines the business development and strategic expansion of Greenway Medical Technologies, a software company delivering electronic healthcare solutions to physicians operating small practices. Over a period of seven years and with an investment of $70 million, Greenway built a best-in-class software application. The case also describes the electronic medical record systems industry ...

Today, wearable health products play a crucial role in most locations, such as constant wellness monitoring of people, street traffic management, weather forecasting, along with smart house. These sensor devices constantly generate massive amounts data and are kept cloud computing. This particular chapter proposes Internet Things design to store system scalable information for healthcare apps. ...

The U.S. pharmaceutical industry plays a vital role in shaping the face of American healthcare. As an industry rooted in innovation, its continued evolution is inherent. With major patent expirations looming and thin product pipelines, the industry now must consider new directions to maintain growth and stability. Follow-on biologics, derived from living organisms and marketed after the patent ...